| Title: Bicalutamide: a new antiandrogen for use in combination with castration for patients with advanced prostate cancer. | |||
| Title Abreviation: Anticancer Drugs | Date of Pub: 1996 Jan | ||
| Author: Blackledge G; Kolvenbag G; Nash A; | |||
| Issue/Part/Supplement: 1 | Volume Issue: 7 | Pagination: 27-34 | |
| MESH Headings: Adult; Aged; Aged, 80 and over; Androgen Antagonists (AD/AE/*TU); Anilides (AD/*TU); Antineoplastic Agents, Hormonal (AE/TU); Combined Modality Therapy; Flutamide (AE/TU); Human; Male; Middle Age; Neoplasms, Hormone-Dependent (*DT/SU); Orchiectomy; Prostatic Neoplasms (*DT/SU); Randomized Controlled Trials; -RN-; | |||
| Journal Title Code: A9F | Publication Type: JOURNAL ARTICLE | ||
| Date of Entry: 961114N | Entry Month: 9701 | ||
| Country: ENGLAND | Index Priority: 2 | ||
| Language: Eng | Unique Identifier: 96361722 | ||
| Unique Identifier: 96361722 | ISSN: 0959-4973 | ||
| Abstract: Maximum androgen blockade, a relatively recent development in the treatment of prostate cancer, combines medical or surgical castration with antiandrogen therapy. A large randomized study comparing the non-steroidal antiandrogen, bicalutamide, with flutamide, each in combination with luteinizing hormone-releasing hormone (LHRH) analogs, showed that after a median follow-up of 49 weeks, the time to treatment failure was significantly longer for the bicalutamide patients compared with the flutamide patients (p = 0.005). After a median follow up to 95 weeks, bicalutamide in combination with LHRH analog therapy produced at least equivalent efficacy with flutamide in combination with LHRH analog therapy in terms of time to treatment failure and equivalent efficacy in terms of survival. The tolerability profile of bicalutamide, as based on reported findings and a literature review, indicates a superior tolerability to that of currently available antiandrogens, particularly with respect to diarrhea with a low incidence of treatment-related withdrawals. | |||
| Abstract By: Author | |||
| Address: Medical Research Department, ZENECA Pharmaceuticals Ltd, Mereside, Macclesfield, UK. | |||
| Number of References: 38 | |||
FACTS ABOUT HAIR TRANSPLANTS:
- Hair transplants are well suited for a majority of candidates
- Follicular unit hair transplants provide natural results
- The only proven permanent solution for hairloss today
Thinking about a
Transplant?
Transplants are safer and
more effective than ever.
Find a hair loss doctor.
Enter you Zip/Postal Code:
» Sponsors
SuperGrow Home Laser
Want faster results? Our new Laser Dome hair laser provides superior coverage and is easy to use. Fast results GUARANTEED!
- Thicker Fuller Hair
- Save Thousands of $$$
- Easiest Laser to Use
Propecia
is used for the treatment of male pattern hair loss (androgenic alopecia) in men. The once a day, FDA approved pill for hair loss.
![]()
Regenepure Shampoo
Healthier, fuller results begin with just one application with the best ingredients for your hair.
- No Lauryl or Laureth Sulfates
- Sulfate and Paraben Free
- Recommended by Physicians
ProMox
Up to 75% more effective on both front and top of the scalp than regular Minoxidil
- Topical Finasteride
- Retin-A and Azeleic Acid
- Spray, Foam or Cream
Avodart
provides superior blocking of the hormone that causes hair loss than Propecia.
![]()
Viagra
Has helped many men who have erectile dysfunction (ED) problems.
![]()








